USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
LAMBDA PHARMACEUTICALS
Address:
1500 SAN JUAN HILLS, STE 203
LAS VEGAS, NV 89134
Phone:
(702) 255-2934
URL:
N/A
EIN:
880372681
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $298,975.00 3
STTR Phase I $99,053.00 1

Award List:

COST EFFECTIVE PHOTOSENSITIZERS FOR USE IN PDT

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$98,975.00
Agency:
HHS
Principal Investigator:
Morgan, alan r
Abstract:
Photodynamic therapy has been approved for certain indications in the USA, Japan, Canada, France and Netherlands. The only drug approved, Photofrin, is not ideal and a significant research effort has led to the development of second generation sensitizers. Many of these agents are hydrophobic and… More

PHOTOFENTON REAGENTS AS PDT SENSITIZERS

Award Year / Program / Phase:
1998 / STTR / Phase I
Award Amount:
$99,053.00
Agency:
HHS
Principal Investigator:
Morgan
Research Institution:
University of Toledo
RI Contact:
N/A
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Robert C. Hall
Abstract:
N/a

Choroidal Neovascular Occlusion Using PDT

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Alan R. Morgan
Abstract:
DESCRIPTION (From the Applicant's Abstract): Photodynamic therapy (PDT) is a new potential treatment of the subfoveal choroidal neovascularization (CNV) that may accompany age-related macular degeneration (AMD). PDT involves the use of a… More